Celldex Therapeutics (CLDX) Cost of Revenue (2024 - 2025)
Historic Cost of Revenue for Celldex Therapeutics (CLDX) over the last 6 years, with Q3 2025 value amounting to $1.1 million.
- Celldex Therapeutics' Cost of Revenue fell 158.29% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year increase of 4618.46%. This contributed to the annual value of $2.3 million for FY2013, which is 7833.87% down from last year.
- Per Celldex Therapeutics' latest filing, its Cost of Revenue stood at $1.1 million for Q3 2025, which was down 158.29% from $1.5 million recorded in Q2 2025.
- In the past 5 years, Celldex Therapeutics' Cost of Revenue ranged from a high of $2.2 million in Q1 2025 and a low of $1.1 million during Q3 2025